High Blood Pressure

Neurology·MeSH: Hypertension

6 drugs in development·6 companies·4 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
exforge hct	Novartis AG (NVS)
felodipine	Mylan II B.V. (MYL)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
telmisartan	Inventiva S.A. (IVA)

BioSniper tracks 6 drugs in development for High Blood Pressure across 6 companies.

There are 4 clinical trials targeting High Blood Pressure tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.